Cargando…

Nanocarriers and nonviral methods for delivering antiangiogenic factors for glioblastoma therapy: the story so far

Angiogenesis, the formation of new blood vessels, is an essential component of glioblastoma (GB) progression. The development of angiogenesis inhibitor therapy, including treatments targeting vascular endothelial growth factor (VEGF) in particular, raised new hopes for the treatment of GB, but no Ph...

Descripción completa

Detalles Bibliográficos
Autores principales:	Clavreul, Anne, Pourbaghi-Masouleh, Milad, Roger, Emilie, Menei, Philippe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6461002/ https://www.ncbi.nlm.nih.gov/pubmed/31040671 http://dx.doi.org/10.2147/IJN.S194858

Ejemplares similares

Development and characterization of sorafenib-loaded lipid nanocapsules for the treatment of glioblastoma
por: Clavreul, Anne, et al.
Publicado: (2018)

Human mesenchymal stromal cells as cellular drug-delivery vectors for glioblastoma therapy: a good deal?
por: Clavreul, Anne, et al.
Publicado: (2017)

QCD at ATLAS: The Story So Far
por: Newman, Paul
Publicado: (2011)

Biology Open: The story so far…
por: Raff, Jordan W., et al.
Publicado: (2015)

Diet and Vitiligo: The Story So Far
por: Dutta, Rajoshee R, et al.
Publicado: (2022)

Amorphous calcium phosphate nanoparticles could function as a novel cancer therapeutic agent by employing a suitable targeted drug delivery platform
por: Pourbaghi-Masouleh, Milad, et al.
Publicado: (2013)

Vitamin D and hippocampal development-the story so far
por: Lardner, Anne L.
Publicado: (2015)

Cannabinoids and Cannabinoid Receptors: The Story so Far
por: Shahbazi, Fred, et al.
Publicado: (2020)

Mesenchymal Stromal-Like Cells in the Glioma Microenvironment: What Are These Cells?
por: Clavreul, Anne, et al.
Publicado: (2020)

Bone targeted treatments in cancer – The story so far
por: Coleman, Robert
Publicado: (2016)

Stem Cell Therapy for Burns: Story so Far
por: Abdul Kareem, Najath, et al.
Publicado: (2021)

Contentious Issues in Gout Management: The Story so Far
por: Talaat, Mohamed, et al.
Publicado: (2021)

Complement Inhibition and COVID-19: The Story so Far
por: Fodil, Sofiane, et al.
Publicado: (2021)

A Simple Preoperative Blood Count to Stratify Prognosis in Isocitrate Dehydrogenase-Wildtype Glioblastoma Patients Treated with Radiotherapy plus Concomitant and Adjuvant Temozolomide
por: Clavreul, Anne, et al.
Publicado: (2021)

Dose-dense chemotherapy for breast cancer: the story so far
por: Hudis, C
Publicado: (2000)

Reflections on dynamic consent in biomedical research: the story so far
por: Teare, Harriet J. A., et al.
Publicado: (2020)

Shapeshifting molecules: the story so far and the shape of things to come
por: Bismillah, Aisha N., et al.
Publicado: (2019)

Inhibition of the IFN Response by Bluetongue Virus: The Story So Far
por: Rojas, José Manuel, et al.
Publicado: (2021)

Factors influencing phagocytosis of malaria parasites: the story so far
por: Chua, Caroline Lin Lin, et al.
Publicado: (2021)

Calixarene-Metal Complexes in Lactide Polymerization: The Story so Far
por: Sachdeva, Garima, et al.
Publicado: (2023)

Targeting and treatment of glioblastomas with human mesenchymal stem cells carrying ferrociphenol lipid nanocapsules
por: Clavreul, Anne, et al.
Publicado: (2015)

Integration of transcriptome and proteome profiles in glioblastoma: looking for the missing link
por: Lemée, Jean-Michel, et al.
Publicado: (2018)

‘From the core to beyond the margin’: a genomic picture of glioblastoma intratumor heterogeneity
por: Aubry, Marc, et al.
Publicado: (2015)

Development and in vitro evaluations of new decitabine nanocarriers for the treatment of acute myeloid leukemia
por: Briot, Thomas, et al.
Publicado: (2017)

Correction: From the core to beyond the margin: a genomic picture of glioblastoma intratumor heterogeneity
por: Aubry, Marc, et al.
Publicado: (2016)

Management of Recurrent Glioblastomas: What Can We Learn from the French Glioblastoma Biobank?
por: Clavreul, Anne, et al.
Publicado: (2022)

The greatest story ever told so far: why are we here?
por: Krauss, Lawrence M
Publicado: (2017)

CAR T-cell immunotherapy of B-cell malignancy: the story so far
por: Halim, Leena, et al.
Publicado: (2020)

Neurological infection with SARS-CoV-2 — the story so far
por: Solomon, Tom
Publicado: (2021)

Big Data Analytics in urology: the story so far and the road ahead
por: Hameed, B. M. Zeeshan, et al.
Publicado: (2021)

Physicochemical Properties and Cellular Responses of Strontium-Doped Gypsum Biomaterials
por: Pouria, Amir, et al.
Publicado: (2012)

The French glioblastoma biobank (FGB): a national clinicobiological database
por: Clavreul, Anne, et al.
Publicado: (2019)

Correction to: The French glioblastoma biobank (FGB): a national clinicobiological database
por: Clavreul, Anne, et al.
Publicado: (2020)

Protein–DNA Interactions: The Story so Far and a New Method for Prediction
por: Jones, Susan, et al.
Publicado: (2003)

Drug safety and immunogenicity of tumour necrosis factor inhibitors: the story so far
por: Jani, Meghna, et al.
Publicado: (2018)

Scoping Review of the Occupational Health and Safety Governance in Sudan: The Story So Far
por: Abdelrahim, Rasha A., et al.
Publicado: (2023)

Cancer stem cells and HER2 positive breast cancer: The story so far
por: Shah, Deep, et al.
Publicado: (2016)

The Story So Far: How Embodied Cognition Advances Our Understanding of Meaning-Making
por: Galetzka, Cedric
Publicado: (2017)

The story so far: Web services are built on the shoulders of earlier technologies, such as client/server and EDI
por: Hayes, F
Publicado: (2003)

Corrigendum: The Story So Far: How Embodied Cognition Advances Our Understanding of Meaning-Making
por: Galetzka, Cedric
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_20oge5vf4jpqo9d8fmlikl2q6r